Global Gene Therapy-based Drug Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gene Therapy-based Drug Market Size 2017-2028

2.1.2 Gene Therapy-based Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Gene Therapy-based Drug Segment by Type

2.2.1 Viral Gene Delivery System

2.2.2 Non-viral Gene Delivery System

2.3 Gene Therapy-based Drug Market Size by Type

2.3.1 Gene Therapy-based Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Gene Therapy-based Drug Market Size Market Share by Type (2017-2022)

2.4 Gene Therapy-based Drug Segment by Application

2.4.1 Neurological Diseases

2.4.2 Cancer

2.4.3 Other

2.5 Gene Therapy-based Drug Market Size by Application

2.5.1 Gene Therapy-based Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Gene Therapy-based Drug Market Size Market Share by Application (2017-2022)

3 Gene Therapy-based Drug Market Size by Player

3.1 Gene Therapy-based Drug Market Size Market Share by Players

3.1.1 Global Gene Therapy-based Drug Revenue by Players (2020-2022)

3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2020-2022)

3.2 Global Gene Therapy-based Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Gene Therapy-based Drug by Regions

4.1 Gene Therapy-based Drug Market Size by Regions (2017-2022)

4.2 Americas Gene Therapy-based Drug Market Size Growth (2017-2022)

4.3 APAC Gene Therapy-based Drug Market Size Growth (2017-2022)

4.4 Europe Gene Therapy-based Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Gene Therapy-based Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Gene Therapy-based Drug Market Size by Country (2017-2022)

5.2 Americas Gene Therapy-based Drug Market Size by Type (2017-2022)

5.3 Americas Gene Therapy-based Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gene Therapy-based Drug Market Size by Region (2017-2022)

6.2 APAC Gene Therapy-based Drug Market Size by Type (2017-2022)

6.3 APAC Gene Therapy-based Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gene Therapy-based Drug by Country (2017-2022)

7.2 Europe Gene Therapy-based Drug Market Size by Type (2017-2022)

7.3 Europe Gene Therapy-based Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gene Therapy-based Drug by Region (2017-2022)

8.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Gene Therapy-based Drug Market Forecast

10.1 Global Gene Therapy-based Drug Forecast by Regions (2023-2028)

10.1.1 Global Gene Therapy-based Drug Forecast by Regions (2023-2028)

10.1.2 Americas Gene Therapy-based Drug Forecast

10.1.3 APAC Gene Therapy-based Drug Forecast

10.1.4 Europe Gene Therapy-based Drug Forecast

10.1.5 Middle East & Africa Gene Therapy-based Drug Forecast

10.2 Americas Gene Therapy-based Drug Forecast by Country (2023-2028)

10.2.1 United States Gene Therapy-based Drug Market Forecast

10.2.2 Canada Gene Therapy-based Drug Market Forecast

10.2.3 Mexico Gene Therapy-based Drug Market Forecast

10.2.4 Brazil Gene Therapy-based Drug Market Forecast

10.3 APAC Gene Therapy-based Drug Forecast by Region (2023-2028)

10.3.1 China Gene Therapy-based Drug Market Forecast

10.3.2 Japan Gene Therapy-based Drug Market Forecast

10.3.3 Korea Gene Therapy-based Drug Market Forecast

10.3.4 Southeast Asia Gene Therapy-based Drug Market Forecast

10.3.5 India Gene Therapy-based Drug Market Forecast

10.3.6 Australia Gene Therapy-based Drug Market Forecast

10.4 Europe Gene Therapy-based Drug Forecast by Country (2023-2028)

10.4.1 Germany Gene Therapy-based Drug Market Forecast

10.4.2 France Gene Therapy-based Drug Market Forecast

10.4.3 UK Gene Therapy-based Drug Market Forecast

10.4.4 Italy Gene Therapy-based Drug Market Forecast

10.4.5 Russia Gene Therapy-based Drug Market Forecast

10.5 Middle East & Africa Gene Therapy-based Drug Forecast by Region (2023-2028)

10.5.1 Egypt Gene Therapy-based Drug Market Forecast

10.5.2 South Africa Gene Therapy-based Drug Market Forecast

10.5.3 Israel Gene Therapy-based Drug Market Forecast

10.5.4 Turkey Gene Therapy-based Drug Market Forecast

10.5.5 GCC Countries Gene Therapy-based Drug Market Forecast

10.6 Global Gene Therapy-based Drug Forecast by Type (2023-2028)

10.7 Global Gene Therapy-based Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Biogen

11.1.1 Biogen Company Information

11.1.2 Biogen Gene Therapy-based Drug Product Offered

11.1.3 Biogen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Biogen Main Business Overview

11.1.5 Biogen Latest Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Gene Therapy-based Drug Product Offered

11.2.3 Novartis Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis Latest Developments

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Information

11.3.2 Gilead Sciences Gene Therapy-based Drug Product Offered

11.3.3 Gilead Sciences Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Gilead Sciences Main Business Overview

11.3.5 Gilead Sciences Latest Developments

11.4 Sarepta Therapeutics

11.4.1 Sarepta Therapeutics Company Information

11.4.2 Sarepta Therapeutics Gene Therapy-based Drug Product Offered

11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Sarepta Therapeutics Main Business Overview

11.4.5 Sarepta Therapeutics Latest Developments

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Information

11.5.2 Alnylam Pharmaceuticals Gene Therapy-based Drug Product Offered

11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Alnylam Pharmaceuticals Main Business Overview

11.5.5 Alnylam Pharmaceuticals Latest Developments

11.6 Amgen

11.6.1 Amgen Company Information

11.6.2 Amgen Gene Therapy-based Drug Product Offered

11.6.3 Amgen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Amgen Main Business Overview

11.6.5 Amgen Latest Developments

11.7 Spark Therapeutics

11.7.1 Spark Therapeutics Company Information

11.7.2 Spark Therapeutics Gene Therapy-based Drug Product Offered

11.7.3 Spark Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Spark Therapeutics Main Business Overview

11.7.5 Spark Therapeutics Latest Developments

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Information

11.8.2 Akcea Therapeutics Gene Therapy-based Drug Product Offered

11.8.3 Akcea Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Akcea Therapeutics Main Business Overview

11.8.5 Akcea Therapeutics Latest Developments

11.9 bluebird bio

11.9.1 bluebird bio Company Information

11.9.2 bluebird bio Gene Therapy-based Drug Product Offered

11.9.3 bluebird bio Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 bluebird bio Main Business Overview

11.9.5 bluebird bio Latest Developments

11.10 Sunway Biotech

11.10.1 Sunway Biotech Company Information

11.10.2 Sunway Biotech Gene Therapy-based Drug Product Offered

11.10.3 Sunway Biotech Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Sunway Biotech Main Business Overview

11.10.5 Sunway Biotech Latest Developments

11.11 SIBIONO

11.11.1 SIBIONO Company Information

11.11.2 SIBIONO Gene Therapy-based Drug Product Offered

11.11.3 SIBIONO Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 SIBIONO Main Business Overview

11.11.5 SIBIONO Latest Developments

11.12 AnGes

11.12.1 AnGes Company Information

11.12.2 AnGes Gene Therapy-based Drug Product Offered

11.12.3 AnGes Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 AnGes Main Business Overview

11.12.5 AnGes Latest Developments

11.13 Orchard Therapeutics

11.13.1 Orchard Therapeutics Company Information

11.13.2 Orchard Therapeutics Gene Therapy-based Drug Product Offered

11.13.3 Orchard Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Orchard Therapeutics Main Business Overview

11.13.5 Orchard Therapeutics Latest Developments

11.14 Human Stem Cells Institute

11.14.1 Human Stem Cells Institute Company Information

11.14.2 Human Stem Cells Institute Gene Therapy-based Drug Product Offered

11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Human Stem Cells Institute Main Business Overview

11.14.5 Human Stem Cells Institute Latest Developments

12 Research Findings and Conclusion

Table 1. Gene Therapy-based Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Viral Gene Delivery System

Table 3. Major Players of Non-viral Gene Delivery System

Table 4. Gene Therapy-based Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Gene Therapy-based Drug Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Gene Therapy-based Drug Market Size Market Share by Type (2017-2022)

Table 7. Gene Therapy-based Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Gene Therapy-based Drug Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Gene Therapy-based Drug Market Size Market Share by Application (2017-2022)

Table 10. Global Gene Therapy-based Drug Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Gene Therapy-based Drug Revenue Market Share by Player (2020-2022)

Table 12. Gene Therapy-based Drug Key Players Head office and Products Offered

Table 13. Gene Therapy-based Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Gene Therapy-based Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Gene Therapy-based Drug Market Size Market Share by Regions (2017-2022)

Table 18. Americas Gene Therapy-based Drug Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Gene Therapy-based Drug Market Size Market Share by Country (2017-2022)

Table 20. Americas Gene Therapy-based Drug Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Gene Therapy-based Drug Market Size Market Share by Type (2017-2022)

Table 22. Americas Gene Therapy-based Drug Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Gene Therapy-based Drug Market Size Market Share by Application (2017-2022)

Table 24. APAC Gene Therapy-based Drug Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Gene Therapy-based Drug Market Size Market Share by Region (2017-2022)

Table 26. APAC Gene Therapy-based Drug Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Gene Therapy-based Drug Market Size Market Share by Type (2017-2022)

Table 28. APAC Gene Therapy-based Drug Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Gene Therapy-based Drug Market Size Market Share by Application (2017-2022)

Table 30. Europe Gene Therapy-based Drug Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Gene Therapy-based Drug Market Size Market Share by Country (2017-2022)

Table 32. Europe Gene Therapy-based Drug Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Gene Therapy-based Drug Market Size Market Share by Type (2017-2022)

Table 34. Europe Gene Therapy-based Drug Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Gene Therapy-based Drug Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Gene Therapy-based Drug Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Gene Therapy-based Drug Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Gene Therapy-based Drug Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Gene Therapy-based Drug

Table 43. Key Market Challenges & Risks of Gene Therapy-based Drug

Table 44. Key Industry Trends of Gene Therapy-based Drug

Table 45. Global Gene Therapy-based Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Gene Therapy-based Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Gene Therapy-based Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Gene Therapy-based Drug Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Gene Therapy-based Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Gene Therapy-based Drug Market Size Market Share Forecast by Application (2023-2028)

Table 51. Biogen Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 52. Biogen Gene Therapy-based Drug Product Offered

Table 53. Biogen Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Biogen Main Business

Table 55. Biogen Latest Developments

Table 56. Novartis Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 57. Novartis Gene Therapy-based Drug Product Offered

Table 58. Novartis Main Business

Table 59. Novartis Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Novartis Latest Developments

Table 61. Gilead Sciences Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 62. Gilead Sciences Gene Therapy-based Drug Product Offered

Table 63. Gilead Sciences Main Business

Table 64. Gilead Sciences Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Gilead Sciences Latest Developments

Table 66. Sarepta Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 67. Sarepta Therapeutics Gene Therapy-based Drug Product Offered

Table 68. Sarepta Therapeutics Main Business

Table 69. Sarepta Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Sarepta Therapeutics Latest Developments

Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 72. Alnylam Pharmaceuticals Gene Therapy-based Drug Product Offered

Table 73. Alnylam Pharmaceuticals Main Business

Table 74. Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Alnylam Pharmaceuticals Latest Developments

Table 76. Amgen Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 77. Amgen Gene Therapy-based Drug Product Offered

Table 78. Amgen Main Business

Table 79. Amgen Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Amgen Latest Developments

Table 81. Spark Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 82. Spark Therapeutics Gene Therapy-based Drug Product Offered

Table 83. Spark Therapeutics Main Business

Table 84. Spark Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Spark Therapeutics Latest Developments

Table 86. Akcea Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 87. Akcea Therapeutics Gene Therapy-based Drug Product Offered

Table 88. Akcea Therapeutics Main Business

Table 89. Akcea Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Akcea Therapeutics Latest Developments

Table 91. bluebird bio Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 92. bluebird bio Gene Therapy-based Drug Product Offered

Table 93. bluebird bio Main Business

Table 94. bluebird bio Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. bluebird bio Latest Developments

Table 96. Sunway Biotech Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 97. Sunway Biotech Gene Therapy-based Drug Product Offered

Table 98. Sunway Biotech Main Business

Table 99. Sunway Biotech Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Sunway Biotech Latest Developments

Table 101. SIBIONO Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 102. SIBIONO Gene Therapy-based Drug Product Offered

Table 103. SIBIONO Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. SIBIONO Main Business

Table 105. SIBIONO Latest Developments

Table 106. AnGes Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 107. AnGes Gene Therapy-based Drug Product Offered

Table 108. AnGes Main Business

Table 109. AnGes Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. AnGes Latest Developments

Table 111. Orchard Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 112. Orchard Therapeutics Gene Therapy-based Drug Product Offered

Table 113. Orchard Therapeutics Main Business

Table 114. Orchard Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Orchard Therapeutics Latest Developments

Table 116. Human Stem Cells Institute Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors

Table 117. Human Stem Cells Institute Gene Therapy-based Drug Product Offered

Table 118. Human Stem Cells Institute Main Business

Table 119. Human Stem Cells Institute Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Human Stem Cells Institute Latest Developments

List of Figures

Figure 1. Gene Therapy-based Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Gene Therapy-based Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Gene Therapy-based Drug Market Size Market Share by Type in 2021

Figure 7. Gene Therapy-based Drug in Neurological Diseases

Figure 8. Global Gene Therapy-based Drug Market: Neurological Diseases (2017-2022) & ($ Millions)

Figure 9. Gene Therapy-based Drug in Cancer

Figure 10. Global Gene Therapy-based Drug Market: Cancer (2017-2022) & ($ Millions)

Figure 11. Gene Therapy-based Drug in Other

Figure 12. Global Gene Therapy-based Drug Market: Other (2017-2022) & ($ Millions)

Figure 13. Global Gene Therapy-based Drug Market Size Market Share by Application in 2021

Figure 14. Global Gene Therapy-based Drug Revenue Market Share by Player in 2021

Figure 15. Global Gene Therapy-based Drug Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Gene Therapy-based Drug Market Size 2017-2022 ($ Millions)

Figure 17. APAC Gene Therapy-based Drug Market Size 2017-2022 ($ Millions)

Figure 18. Europe Gene Therapy-based Drug Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Gene Therapy-based Drug Market Size 2017-2022 ($ Millions)

Figure 20. Americas Gene Therapy-based Drug Value Market Share by Country in 2021

Figure 21. Americas Gene Therapy-based Drug Consumption Market Share by Type in 2021

Figure 22. Americas Gene Therapy-based Drug Market Size Market Share by Application in 2021

Figure 23. United States Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Gene Therapy-based Drug Market Size Market Share by Region in 2021

Figure 28. APAC Gene Therapy-based Drug Market Size Market Share by Application in 2021

Figure 29. China Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Gene Therapy-based Drug Market Size Market Share by Country in 2021

Figure 36. Europe Gene Therapy-based Drug Market Size Market Share by Type in 2021

Figure 37. Europe Gene Therapy-based Drug Market Size Market Share by Application in 2021

Figure 38. Germany Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Application in 2021

Figure 46. Egypt Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Gene Therapy-based Drug Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 52. APAC Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 53. Europe Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 55. United States Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 56. Canada Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 59. China Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 60. Japan Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 61. Korea Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 63. India Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 64. Australia Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 65. Germany Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 66. France Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 67. UK Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 68. Italy Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 69. Russia Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 70. Spain Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 73. Israel Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Gene Therapy-based Drug Market Size 2023-2028 ($ Millions)